BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 27
• 28
• 29
• 30

• Business

  Protagen AG Successfully Joined Forces With Novartis AG To Support Clinical Development Of A Novel Compound In An Autoimmune Indication

  December 20, 2016

   · 

  1 min read
• Drug Development

  AmpliPhi Bio Reports Favorable Final Results From Phase 1 Trial Of AB-SA01 In Chronic Rhinosinusitis Patients

  December 20, 2016

   · 

  4 min read
• Drug Development

  GenSight Biologics Reports Sustained Visual Acuity Gain At 78 Weeks In Its Phase I/II Study With GS010 For The Treatment Of Leber’s Hereditary Optic Neuropathy (LHON)

  December 20, 2016

   · 

  5 min read
• Pharm Country

  Clinical Genomics Pty Ltd Announces The Launch Of Colvera For Colorectal Cancer Recurrence Monitoring

  December 20, 2016

   · 

  4 min read
• Deals

  TiGenix Announces Closing Of NASDAQ IPO

  December 20, 2016

   · 

  1 min read
• Business

  Patheon Reports Growth Across All Segments For Fourth Quarter; Provides Outlook For Fiscal Year 2017

  December 20, 2016

   · 

  1 min read
• Drug Development

  Eyenovia Announces Completion Of Second Phase II Study

  December 20, 2016

   · 

  2 min read
• FDA

  Celgene Release: Oral PDE-4 Inhibitor, OTEZLA, Approved For The Treatment Of Plaque Psoriasis And Psoriatic Arthritis In Japan

  December 20, 2016

   · 

  8 min read
• Business

  22nd Century Group, Inc. Announces Major Scientific Collaboration With University of Virginia

  December 20, 2016

   · 

  5 min read
• Pharm Country

  Interpace Diagnostics Announces $1.9 Million Registered Direct Offering Of Common Stock

  December 20, 2016

   · 

  5 min read